Loading...
•
Jun 30, 2024
Conmed Q2 2024 Earnings Report
Second quarter 2024 financial results were announced, with revenue impacted by supply chain challenges.
Key Takeaways
CONMED Corporation reported its second quarter 2024 financial results, noting that the quarter played out largely as expected but the company has not yet fully recovered from supply chain challenges, delaying commercial reacceleration. The full-year revenue guidance was revised to $1.305 billion to $1.315 billion, and adjusted diluted net earnings per share are now expected to be in the range of $3.95 to $4.02.
Second quarter 2024 results played out largely as expected.
Supply chain challenges have delayed commercial reacceleration.
Full-year reported revenue is now expected to be between $1.305 billion and $1.315 billion.
Full-year adjusted diluted net earnings per share are expected to be between $3.95 and $4.02.
Conmed
Conmed
Forward Guidance
CONMED expects full-year reported revenue to be between $1.305 billion and $1.315 billion. The Company now expects full-year adjusted diluted net earnings per share in the range of $3.95 to $4.02.